The Dublin-based Botox-maker Allergan announced early Wednesday it would abandon its mega-merger with U.S. phamaceutical giant Pfizer after new government regulations made the tax advantage of the cross-Atlantic deal more difficult to achieve.
The move is a huge victory for the Obama administration in its campaign against inversions, in which U.S.-based companies buy or merge with a smaller foreign firm and move their headquarters overseas in order to lower their tax bill. The Treasury Department released new regulations Monday to stem th...
12:33 Kraft Heinz to pursue merger despite Unilever rejection19
22:09 Cigna demands Anthem pay $14.8 billion in lawsuit to terminate merger agreement30
18:17 Kraft Heinz Withdraws $143 Billion Offer to Merge With Unilever25
14:55 Kraft won't back down from Unilever merger pursuit despite rejection21